Document is current

Article History

Received: 14 November 2024

Accepted: 20 November 2024

First Online: 13 December 2024

Declarations

:

: Not applicable.

: Not applicable.

: Dr. Bruemmer serves as a consultant for Bayer Pharmaceuticals, Inc., Eli Lilly and Company, and Esperion Therapeutic, Inc. DB performs research with Novartis.Dr. Chung has received funds for service on the American Board of Internal Medicine and as an Associate Editor for Circulation:Arrhythmia & Electrophysiology; she has received royalties from UpToDate and Elsevier. She receives funding as noted under Sources of Funding.Dr. Laffin serves/served as a consultant or on steering committees for Recor, Medtronic, Eli Lilly, Mineralys, Crispr Therapeutics, Idorsia, Novo Nordisk, Arrowhead Pharmaceuticals, Ripple Medical, and Stability Health. He has received research funding from AstraZeneca for studies of rosuvastatin. He receives royalties from Belvoir Media Group, Elsevier, and Springer Nature.Dr. Mehra has received an honorarium from the American Academy of Sleep Medicine; has received funds for service on the American Board of Internal Medicine writing group and as associate editor of the American Journal of Respiratory and Critical Care Medicine; has received National Institutes of Health funding (R21HL170206); funding from the Women in Alzheimer’s Movement; funds from Eli Lilly and Mineralys; and has received royalties from UpToDate.Dr. Nissen reports that the Cleveland Clinic Center for Clinical Research has received funding to perform clinical trials from Abbvie, AstraZeneca, Amgen, Arrowhead, Bristol Myers Squibb, Eli Lilly, Esperion, Medtronic, MyoKardia, New Amsterdam Pharmaceuticals, Novartis, Pfizer, and Silence Therapeutics. Dr. Nissen is involved in these clinical trials but receives no personal remuneration for his participation. Dr. Nissen consults for these pharmaceutical companies, but does not accept compensation.Dr. Saliba serves on advisory boards for Boston Scientific and Biosense Webster.Dr. Sanders is supported by an Investigator Grant Fellowship from the National Health and Medical Research Council of Australia. Dr. Sanders reports serving on the advisory board for Medtronic, Abbott Medical, Boston-Scientific, CathRx and Pacemate. PS reports that the University of Adelaide receives on his behalf research funding from Medtronic, Abbott Medical, Boston-Scientific, and Becton Dickenson.